Industry
Health Care
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Health Care
... ORIGINAL ANNOUNCEMENT [Text] Canada NewsWire VANCOUVER, Nov. 20, 2017 Provides Comments on CanniMed's Poison Pill Tactic Aurora's proposed offer currently valued at $24.00 per CanniMed ...
... VANCOUVER, British Columbia, Nov. 20, 2017 -- Harvest One Cannabis Inc. (TSX-V:HVST) ("Harvest One" or the "Company") is pleased to advise that its wholly owned ...
... [Text] TORONTO, Nov. 20, 2017 -- At the request of IIROC, Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT) wishes to confirm that the Company's ...
... [Text] VANCOUVER, British Columbia, Nov. 20, 2017 -- Calyx Bio-Ventures Inc. (TSXV:CYX) ("Calyx" or the "Company") is pleased to announce that it has established a ...
... to further strategically position the Company together with its European partner, U-Protein Express B.V. to pursue expansion into the European market and growth initiatives globally. ...
... REPORT Corporate Wire Date: 20 November 2017 14:32 EST ORIGINAL ANNOUNCEMENT [Text] Theralase Discovers New Anti-Cancer Vaccine Toronto, Ontario (FSCwire) - Theralase Technologies Inc. ("Theralase" ...
... growth capital to successful mid-market companies, today announced the repayment by Medicure Inc. ("Medicure") (TSXV: MPH) of a special situations loan managed by Crown. Medicure ...
... Wire Date: 20 November 2017 09:12 EST ORIGINAL ANNOUNCEMENT [Text] Agility Health, Inc. (TSX VENTURE:AHI) ("Agility Health" or the "Company"), today reports its financial results ...
... Brisbane-based Blue Sky is hoping its next deal will be as easy as ABC, ...
... show chapters Arrivo Arrivo's BamBrogan: Hyperloop will be more commercially viable 4 Hours Ago | ...
... York (November 20, 2017, 3:08 PM EST) -- Investors suing biopharmaceutical company CytRx Corp. for allegedly misrepresenting the success of a late-stage trial of a ...
... bargaining chip in the Senate tax-cut debate. He sat down in Nashville's Bluebird Café, the songwriter's haven where Taylor Swift once found her breakthrough, to ...
... he ran the company’s Esoteric Business Unit and was a member of LabCorp’s five-person Executive Committee. He also previously served as LabCorp’s head of Strategic ...
... be an extremely busy travel week by offering more flights and destinations. CVG expects more than 150,000 passengers during the Thanksgiving travel period (Nov. 19-26). ...
... ONSOLIS (fentanyl buccal soluble film) (CII) is licensed in the U.S. to Collegium Pharmaceutical pursuant to the U.S. licensing and development agreement between BDSI and ...
... SAN CLEMENTE, California - ICU Medical, Inc. a worldwide leader in the development, manufacture, and sale of innovative ...
... New York on November 28, 2017 at 3:00 p.m. Eastern Time. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that ...
... Oncoinvent announced today that European Patent 3111959 entitled 'Radiotherapeutic particles and suspensions' has ...
... NEW HAVEN, Conn. - Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced that it is completing enrollment today in the ...
... Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shinichi ...
... for a promising treatment option for this disease.' Alnylam, in alliance with Sanofi Genzyme, plans to submit a Marketing Authorisation Application to the European Medicines ...
... Durham, NC (USA) - Alcami Corporation, a leading provider of custom end-to-end development and manufacturing services for ...
... CAMBRIDGE, Mass. - Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients ...
... TORONTO - Alternate Health Corp ('Alternate Health' or the 'Company') (CSE: AHG) (OTC: AHGIF), an international, vertically-integrated ...
... dr. Marc Bonten, head of the Department of Medical Microbiology at University Medical Center Utrecht (the Netherlands) and academic lead of the COMBACTE program: 'The ...
... has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen) for which Ionis earned $ 5 million. IONIS-JBI2-2.5Rx is designed ...
... Plano, Texas - Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, ...
... September 30, 2017, revenue results from the co-development and commercialization agreement with AstraZeneca, corresponding to the recognition over the period of the initial payment received ...
... Colorado. Mr. Swirsky was most recently President, CEO and a director of GenVec, Inc., a publicly-traded biotechnology company, a position he held from 2013 through ...
... Leuven (BELGIUM) - CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on ...
... BRIDGEWATER, New Jersey - Bausch + Lomb, a leading global eye health company, announces today, on America Recycles ...
... Aviv district court ordered MediWound to purchase approximately $ 1.5 million of PolyHeal shares; MediWound weighing an appeal. Positive decision of European Commission on a ...
... REDWOOD CITY, Calif. - AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization ...
... Executive Officer of several biopharma companies and more than 17 years at Pfizer, where he held leadership positions in corporate strategic planning, acquisitions and business ...
... Executive Vice President, Global Head R&D, and Chief Medical Officer of Jazz Pharmaceuticals, Inc. Dr. Smithbrings over 20 years of experience in drug development, regulatory, ...
... NEW HAVEN, Conn. - Achillion Pharmaceuticals, Inc. ('Achillion') (NASDAQ: ACHN) today announced the pricing of an underwritten public ...
... SAN DIEGO - Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today reported financial results for the ...
... HOPKINTON, Mass. - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced top-line results from the second ...
... Copenhagen, Denmark - Zealand Pharma announces that all subjects have been enrolled and dosed in a ...
... As part of National Alzheimer's Disease Awareness Month in November, Janssen Research & Development, LLC ('Janssen') today launched a new digital news series about this ...
... Berlin - Bayer and PeptiDream, a public Japanese biopharmaceutical company, have entered into a global drug discovery ...
... organization announced last week. It will also include partnerships that will grow Geisinger's precision medicine program nationally. The Pennsylvania-based integrated health services organization has hired ...
... clinical trial for metastatic melanoma alongside PD-1 drugs. ( Reuters ) 3. Loxo Oncology will receive up to $1.55 billion from Bayer to co-develop and ...
... Diabetes Ads Campaign: For Your Sweetheart Celebrity: Angela Bassett Companies: Eli Lilly, Boehringer Ingelheim Actress Angela Bassett shares her personal connection with diabetes in the ...
... 1. The FDA approved benralizumab, AstraZeneca's drug for severe asthma, which will be known as Fasenra. It is ...
... University. ( Reuters ) 2. The U.S. Department of Justice is investigating Astellas Pharma's financial support of charities that offer Medicare assistance. ( Reuters ) ...
... offer short answers," said Ryan Billings, senior director of digital innovation at Amag Pharmaceuticals. Added Andrew Grojean, social media manager at Intouch Solutions, "Increased characters ...
... Novartis-backed biotech Gamida Cell has named Julian Adams, Ph.D.—its current chair and chief scientific officer ...
... Organization (MSO) in February 2017 as a practice management services organization. Grand Rapids Ophthalmology partnered with the MSO to pursue growth opportunities, evolve clinical capabilities ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤